Yung-Yeh Su, Nai-Jung Chiang, Tai-Jan Chiu, Chien-Jui Huang, Shao-Jung Hsu, Hsin-Chen Lin, Shih-Hung Yang, Youngsen Yang, Wen-Chi Chou, Yen-Yang Chen, Li-Yuan Bai, Chung-Pin Li, Jen-Shi Chen
Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Over the past decade, significant therapeutic advancements have improved the survival rates of patients with pancreatic cancer. One of the primary factors contributing to these positive outcomes is the evolution of chemotherapy, from monotherapy to doublet or triplet regimens, and the integration of multimodal approaches. Additionally, targeted agents tailored to patients with specific genetic alterations and the development of cell therapies show promise in benefiting certain subpopulations...
December 31, 2023: Biomedical Journal